VINZENZ GRUPPE
     
 

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.

Gnant, M, Pfeifer, G, Stöger, H, Mlineritsch, B, Fitzal, F, Balic, M, Kwasny, W, Seifert, M, Stierer, M, Dubsky, P, Steger, G, Samonigg, H, Fesl, C and Jakesz, R (2013) The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial. [Fachpublikation (peer reviewed)]

Full text not available from this repository.
Item Type: Fachpublikation (peer reviewed)
Divisions: Ordensklinikum Linz Barmherzige Schwestern > Allgemeinchirurgie mit Viszeralchirurgie
Depositing User: Manuela Schühler
Date Deposited: 16 Jun 2014 07:30
Last Modified: 16 Jun 2014 07:30
URI: http://eprints.vinzenzgruppe.at/id/eprint/7140

Actions (login required)

View Item
View Item